about
Cannabis and psychosis/schizophrenia: human studiesThe mental health risks of adolescent cannabis use.Substance use in clinical high risk for psychosis: a review of the literatureGone to Pot - A Review of the Association between Cannabis and PsychosisEmerging psychosis and the family.Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?Cannabis use and psychosis: a review of clinical and epidemiological evidence.Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Cannabis use disorders in schizophrenia: effects on cognition and symptomsOxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognitionUltra high risk of psychosis on committal to a young offender prison: an unrecognised opportunity for early intervention.Pathways from cannabis to psychosis: a review of the evidence.Interpreting the association between cannabis use and increased risk for schizophreniaTreated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment areaSubstance abuse in first-episode schizophrenic patients: a retrospective studyCannabis use predicts future psychotic symptoms, and vice versa.Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.Impact of Cannabis Use on the Development of Psychotic DisordersDifferential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review.Risk and protective factors associated with substance use disorders in adolescents with first-episode maniaClinical aspects of substance abuse in persons with schizophrenia.Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review.The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis.Substance abuse in patients with schizophrenia.The epidemiology of schizophrenia: replacing dogma with knowledgeA randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.Cannabis abuse and risk for psychosis in a prodromal sample.Cannabis use and the mental health of young people.Status of first-episode psychosis patients presenting for routine care in a defined catchment area.Is cannabis use a contributory cause of psychosis?Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.Drug and alcohol misuse in first episode psychosis: An observational study.Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.Early detection and intervention of psychosis. A review.Substance misuse and early psychosis.Prevalence of cannabis residues in psychiatric patients: a case study of two mental health referral hospitals in UgandaPremorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?
P2860
Q24628837-9CD6B9FA-B58D-4A8E-9070-F0658ABE8025Q25256922-F9CD1917-84C4-45AA-90C7-E83E280EF564Q26859349-9B8D2AF9-6890-475B-B0BF-C724C3D7961EQ26865311-5936A07B-C0E5-44BA-93CE-A9842B16EB21Q30453842-CD9AA7CC-6466-4113-A3E0-13205D16389AQ31095554-8D85A843-E8D0-40E9-9885-40DFBEE36591Q31149257-E33330D8-584F-415E-9DBB-9DCA55C51CF0Q33933884-1C3C8E10-6E0D-4FBD-B251-E084A859B58FQ33976751-C7E868F9-B681-461F-A808-E2A337A3AB32Q33985743-02C3F32F-8AB6-4D07-AE80-74CDA1B81EB0Q34270701-0F636E88-53EF-423B-9B90-82B90F4D284EQ34365907-08DE1AEF-9EEF-4DDE-99A0-9592CEC74A68Q34378233-C03130EE-667D-4DB6-A189-A23834091E22Q34439127-2D303707-52AC-413A-9932-FB4DE79A03C1Q34464734-198D35CC-2262-4B05-849D-2396B370CF05Q34537645-5D737572-FA19-4D48-9930-B3D33E539AA5Q34557027-AF224BE3-9533-4B20-B161-8F33801AAF72Q34612418-3DF7F991-CEA0-4C9F-9CFB-BE650B94D84AQ34668606-4EBA2EAB-1788-45FC-B734-3F140D79A801Q34744036-73E00826-BD0A-476E-8A0C-7D5EE4391F88Q34889141-DA6EAB3B-9C5F-4A7F-8AB3-B1F0924D4DC5Q35084956-D076EFA0-D5CF-48D1-89B8-CDDBF4B0DA2AQ35136787-90A999AE-2FE1-4C83-8298-2D73908F4170Q35205829-9BAC54C5-9473-4E12-BE53-482AD8AED8E1Q35236574-E035AA91-38FF-4D3B-9606-6CEE9B488087Q35236689-427EA0D2-7E95-4C9F-97B9-B61235A5710DQ35237282-BEAEBCC1-D62F-4B7E-B595-EADD53BA769BQ35529636-1BD3593E-91E3-4CE8-84D0-D1A004DA285FQ36059843-B93835F0-19B0-4607-A794-D85FE2C5F8A2Q36148531-B62E9A35-741F-41EA-A561-14D3BF83BE7FQ36395724-43F48CA9-D4C9-4499-BB06-49E842CD76DEQ36402481-6C63602E-99BB-445C-B687-0F7D51E162DAQ36606244-0FFC3284-C4C8-42F6-B030-B99AAB407958Q36770060-2584C309-CD85-432E-91B2-32A43642363EQ36842165-42DF4B9C-E6F4-4E1B-BC11-06691F533AADQ37057539-643A4052-29CD-4C7E-9DA8-D90083D51221Q37196812-43B174EE-304F-40FC-8B45-6BBAD1E43DB2Q37419167-77D4BAAA-ACE6-43E5-8648-A24AF12AD038Q37478500-AF0E276B-E09D-4D71-B087-FBCF2F0BFB3BQ37703821-BBBA1366-E18C-4A2B-B71C-96091F9CAE69
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Substance abuse and the onset of schizophrenia.
@en
Substance abuse and the onset of schizophrenia.
@nl
type
label
Substance abuse and the onset of schizophrenia.
@en
Substance abuse and the onset of schizophrenia.
@nl
prefLabel
Substance abuse and the onset of schizophrenia.
@en
Substance abuse and the onset of schizophrenia.
@nl
P1476
Substance abuse and the onset of schizophrenia.
@en
P2093
P304
P356
10.1016/S0006-3223(95)00609-5
P407
P577
1996-12-01T00:00:00Z